Isabelle B. Cooperstein, BS is the 2025 recipient of the ACMG Foundation/Revvity Early Career Travel Award. The ACMG Foundation for Genetic and Genomic Medicine presented Ms. Cooperstein this award ...

PRIME lamb producers will get practical insights into how genetics can perform on farm, at a workshop in Gundagai this Friday ...

Efficiency is driving the move into intensive dairying with up to 10 per cent of the nation’s herd now housed in an ...

After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with an intrathecal formulation intended for older patients.

Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to ...

In an age where algorithms influence what we see, hear and believe, are we still the decision-makers, or have we given the ...

Genetic and genomic testing guide breast cancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami ...

The public offering was led by Perceptive Advisors and Nantahala Capital, with participation from other new institutional biotech investors. Company CEO George Magrath and board chairman Cam Gallagher ...

Natera offers robust growth with strong financials and innovative tests. Find out why NTRA stock is a Buy, despite potential ...

Featured Scientific Session: "Evolution of Cytogenomic Technology: Real-World Applications of Optical Genome Mapping in the Laboratory", an accredited continuing medical education (CME) session, with ...

Myriad Genetics, Inc., a molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally. The company offers molecular ...

A major milestone on March 14th 2025 advanced the EU Trilogue discussions aimed to complete the final text of the New Genomic Techniques (NGTs) ...